SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 197.62+0.1%Dec 24 12:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Don S.Boller who wrote (29226)8/31/1999 10:14:00 PM
From: bob zagorin  Read Replies (1) of 32384
 
IMHO, LGND is still a late development stage bio moving toward becoming a pharm. At this point, test results on major technology platforms are far more important than timing on sales of two acquired products. LGND deserves criticism for letting these timelines slip but NBD. LGND has plenty of cash drawn down at $14 / share from Elan. i've got allthe LGND I can handle right now but IMHO this is overreaction by both the analysts and investors.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext